1-6 of 6
ponatinib
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ponatinib coronary microangiopathy: novel bedside diagnostic approach and management with N -acetylcysteine

Clinical Trials & Observations
Melinda D. Wu, James Hodovan, Kris Kumar, Bart Moulton, Sven Olson, Aubre Gilbert, Matthew D. Wood, Jonathan R. Lindner
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4083–4085.
https://doi.org/10.1182/bloodadvances.2020002644
Published: 2020
Includes: Supplemental data
Journal Articles

First-line imatinib vs second- and third-generation TKIs for chronic-phase CML: a systematic review and meta-analysis

Clinical Trials & Observations
Claudia Vener, Rita Banzi, Federico Ambrogi, Annalisa Ferrero, Giuseppe Saglio, Gabriella Pravettoni, Milena Sant
Journal: Blood Advances
Blood Adv (2020) 4 (12): 2723–2735.
https://doi.org/10.1182/bloodadvances.2019001329
Published: 2020
Includes: Supplemental data
Journal Articles

Poor tolerability to ponatinib in Indian CML patients

Clinical Trials & Observations
Charanpreet Singh, Arihant Jain, Deepesh Lad, Gaurav Prakash, Alka Khadwal, Dinesh Bhurani, Rayaz Ahmed, Narendra Agrawal, Jose Easow, Neelam Varma, Pankaj Malhotra
Journal: Blood Advances
Blood Adv (2020) 4 (9): 1927–1929.
https://doi.org/10.1182/bloodadvances.2020001944
Published: 2020
Journal Articles

Side-effects profile and outcomes of ponatinib in the treatment of chronic myeloid leukemia

Clinical Trials & Observations
Onyee Chan, Chetasi Talati, Leidy Isenalumhe, Samantha Shams, Lisa Nodzon, Michael Fradley, Kendra Sweet, Javier Pinilla-Ibarz
Journal: Blood Advances
Blood Adv (2020) 4 (3): 530–538.
https://doi.org/10.1182/bloodadvances.2019000268
Published: 2020
Journal Articles

Ponatinib treatment promotes arterial thrombosis and hyperactive platelets

Alona Merkulova, Steven C. Mitchell, Evi X. Stavrou, Gabriel L. Forbes, Alvin H. Schmaier
Journal: Blood Advances
Blood Adv (2019) 3 (15): 2312–2316.
https://doi.org/10.1182/bloodadvances.2019000034
Published: 2019
Includes: Supplemental data
Journal Articles

Analysis of cardiovascular and arteriothrombotic adverse events in chronic-phase CML patients after frontline TKIs

Clinical Trials & Observations
Preetesh Jain, Hagop Kantarjian, Prajwal C. Boddu, Graciela M. Nogueras-González, Srdan Verstovsek, Guillermo Garcia-Manero, Gautam Borthakur, Koji Sasaki, Tapan M. Kadia, Princy Sam, Hycienth Ahaneku, Susan O’Brien, Zeev Estrov, Farhad Ravandi, Elias Jabbour, Jorge E. Cortes
Journal: Blood Advances
Blood Adv (2019) 3 (6): 851–861.
https://doi.org/10.1182/bloodadvances.2018025874
Published: 2019
Includes: Supplemental data